ArticleJournal of the National Cancer Institute2019

Cost-Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia.

Reith R Sarkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.